New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - diclofenac sodium 50mg - enteric coated tablet - 50 mg - active: diclofenac sodium 50mg excipient: colloidal silicon dioxide dextrates hypromellose iron oxide yellow   macrogol 3350 magnesium stearate methanol methylcellulose polyvinylacetate phthalate purified water stearic acid   sunset yellow aluminium lake   titanium dioxide   triethyl citrate - diclofenac is used for the relief of moderate pain and inflammation in: 1. rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. 2. acute attacks of gout. 3. painful post-operative inflammation and swelling (including dental and orthopaedic procedures). 4. painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. 5. as an adjuvant in severe painful inflammatory infections of the ear, nose or throat. 6. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

Canada - English - Health Canada

actavis pharma company - diclofenac sodium; misoprostol - tablet (enteric-coated) - 50mg; 200mcg - diclofenac sodium 50mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

actavis pharma company - diclofenac sodium; misoprostol - tablet (enteric-coated) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

apotex inc - diclofenac sodium - tablet (enteric-coated) - 25mg - diclofenac sodium 25mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

apotex inc - diclofenac sodium - tablet (enteric-coated) - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

avanstra inc - diclofenac sodium - tablet (enteric-coated) - 25mg - diclofenac sodium 25mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

avanstra inc - diclofenac sodium - tablet (enteric-coated) - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents

Ireland - English - HPRA (Health Products Regulatory Authority)

stada arzneimittel ag - diclofenac sodium - tablets - 50 milligram

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

hashim pharmacy - diclofenac sodium - enteric coated tablet - 50

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - omeprazole, quantity: 20 mg - tablet, enteric coated - excipient ingredients: iron oxide black; microcrystalline cellulose; povidone; iron oxide red; crospovidone; purified talc; lactose monohydrate; hypromellose phthalate; magnesium stearate; triacetin; ascorbyl palmitate - omeprazole tablets are indicated for: a. gastro-oesophageal reflux disease (gord): 1. symptomatic gord: the relief of heartburn and other symptoms associated with gord. 2. erosive oesophagitis: the treatment and prevention of relapse. b. peptic ulcers: 1. the treatment of duodenal and gastric ulcer. 2. combination therapy for the treatment of peptic ulcer disease associated with heliobacter pylori infection. 3. the treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs. 4. the prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. 5. long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be heliobacter pylori negative, or in whom eradication is inappropriate, e.g. the elderly, or ineffective. c. zollinger-ellison syndrome: the treatment of zollinger-ellison syndrome.